Dichloromethane → (R)-3-pyrrolidin-3-yl-4H-1,2,4-oxadiazol-5-one

HRID 1040415ノート

反応式

HRID 1040415 の反応式
C(OC([N:8]1[CH2:12][CH2:11][C@@H:10]([C:13]2[NH:17][C:16](=[O:18])[O:15][N:14]=2)[CH2:9]1)=O)(C)(C)C.C(Cl)Cl.C1(S)C=CC=CC=1>C(O)(C(F)(F)F)=O>[NH:8]1[CH2:12][CH2:11][C@@H:10]([C:13]2[NH:17][C:16](=[O:18])[O:15][N:14]=2)[CH2:9]1

参加物

5

反応物 3

HCID 6344DichloromethaneHCID 7969ThiophenolHCID 136383477(R)-3-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester

生成物 1

HCID 136383470(R)-3-pyrrolidin-3-yl-4H-1,2,4-oxadiazol-5-one収率 91.1%

試薬・触媒・溶媒 1

HCID 6422Trifluoroacetic acid溶媒

実験手順

Crude (R)-3-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-pyrrolidine-1-carboxylic acid tert-butyl ester (872 mg, 3.41 mmol), CH2Cl2 (5 mL) and thiophenol (0.7 mL, 6.8 mmol) were combined and diluted with TFA (5 mL). After 24 h, the reaction was concentrated in vacuo. The residue was partitioned between CH2Cl2 and water. The layers were separated and the CH2Cl2 layer was extracted with water. The combined aqueous layers were concentrated in vacuo. Reverse phase HPLC purification yielded 482 mg of (R)-3-pyrrolidin-3-yl-4H-1,2,4-oxadiazol-5-one as a tan oil (˜50% pure) that was used without further purification.

後処理

  1. concentrationthe reaction was concentrated in vacuo
  2. customThe residue was partitioned between CH2Cl2 and water
  3. customThe layers were separated
  4. extractionthe CH2Cl2 layer was extracted with water
  5. concentrationThe combined aqueous layers were concentrated in vacuo
  6. customReverse phase HPLC purification

出典と根拠

ORDレコード
ord-13e92986632d44e498977bc5e7910043
出典データセット
uspto-grants-2013_10
特許番号
US08552205B2

反応ノート

読み込み中…